Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VOICE: Vadadustat for Anemia in Hemodialysis Subjects
NCT06520826Phase 3Active, not recruiting
- Sponsor
- U.S. Renal Care
- Start
- Nov 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vadadustat in anemia of chronic kidney disease (CKD-A), sponsored by U.S. Renal Care. Started Nov 2024; status: active, not recruiting.
02
Drugs
vadadustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT06520826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06520826.